216 related articles for article (PubMed ID: 9048401)
1. Low-molecular-weight heparin: from the bench to the orthopedic patient.
Turpie AG
Orthopedics; 1997 Feb; 20 Suppl():10-3. PubMed ID: 9048401
[TBL] [Abstract][Full Text] [Related]
2. Low-molecular-weight heparin: from the bench to the orthopedic patient.
Turpie AG
Orthopedics; 1997 Feb; 20():10-3. PubMed ID: 24826689
[TBL] [Abstract][Full Text] [Related]
3. Low-molecular-weight heparin in the treatment of deep venous thrombosis.
Hauer KE
West J Med; 1998 Oct; 169(4):240-4. PubMed ID: 9795594
[TBL] [Abstract][Full Text] [Related]
4. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery.
Bergqvist D
Br J Surg; 2004 Aug; 91(8):965-74. PubMed ID: 15286956
[TBL] [Abstract][Full Text] [Related]
5. [Assessment of complications of major orthopedic surgery: comparison of indobufen, calcium heparin, and low molecular heparin].
Borghi B; Bassi A; Grazia M; Feoli MA; Pignotti E
Minerva Anestesiol; 1996 Mar; 62(3):93-100. PubMed ID: 8767154
[TBL] [Abstract][Full Text] [Related]
6. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
Holzheimer RG
Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
[TBL] [Abstract][Full Text] [Related]
7. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
8. [Low molecular weight heparins].
Agnelli G; Cosmi B
Medicina (Firenze); 1990; 10(1):9-15. PubMed ID: 2166209
[TBL] [Abstract][Full Text] [Related]
9. Low molecular weight heparin for the out-of-hospital treatment of venous thrombosis: rationale and clinical results.
Hirsh J; Crowther M
Thromb Haemost; 1997 Jul; 78(1):689-92. PubMed ID: 9198240
[TBL] [Abstract][Full Text] [Related]
10. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
11. Treatment of deep vein thrombosis using low-molecular-weight heparins.
Groce JB
Am J Manag Care; 2001 Nov; 7(17 Suppl):S510-5; discussion S515-23. PubMed ID: 11732662
[TBL] [Abstract][Full Text] [Related]
12. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
Hull RD; Pineo GF; Stein P
Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
[TBL] [Abstract][Full Text] [Related]
13. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
14. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
Kamphuisen PW; Agnelli G
Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery.
Mismetti P; Laporte S; Darmon JY; Buchmüller A; Decousus H
Br J Surg; 2001 Jul; 88(7):913-30. PubMed ID: 11442521
[TBL] [Abstract][Full Text] [Related]
16. Low molecular weight heparin for the prevention and treatment of venous thromboembolism.
Raskob GE
Curr Opin Pulm Med; 1996 Jul; 2(4):305-10. PubMed ID: 9363157
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of Clivarin and other LMWHs in general surgery: a meta-analysis.
Kakkar VV
Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S23-7; discussion S29-31. PubMed ID: 8180326
[TBL] [Abstract][Full Text] [Related]
18. Low-molecular-weight heparin for the out-of-hospital treatment of venous thrombosis: rationale and clinical results.
Crowther M; Hirsh J
Semin Thromb Hemost; 1997; 23(1):77-81. PubMed ID: 9156414
[TBL] [Abstract][Full Text] [Related]
19. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
Nishioka J; Goodin S
J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
[TBL] [Abstract][Full Text] [Related]
20. Heparin and low-molecular-weight heparin therapy for venous thromboembolism: will unfractionated heparin survive?
Hull RD; Pineo GF
Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():11-23. PubMed ID: 15085462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]